The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamm, A.
Right arrow Articles by Schmidt, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamm, A.
Right arrow Articles by Schmidt, R. E.

The Journal of Immunology, Vol 157, Issue 4 1576-1581, Copyright © 1996 by American Association of Immunologists


ARTICLES

The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding

A Tamm and RE Schmidt
Department of Clinical Immunology, Hannover Medical School, Germany.

Numerous mAbs have been generated against Fc gamma RIII (CD16), the low- affinity receptor for the Fc part of IgG. Most of the mAbs recognize both the receptor isoforms, transmembranous Fc gamma RIIIA, and glycosylphosphatidylinositol-linked Fc gamma RIIIB. Binding epitopes of some of the mAbs that differentiate between the two neutrophil Ag (NA) alleles of Fc gamma RIIIB (CLB-Gran11 against NA1; GRM1, BL-LGL/1 against NA2 allele) have been mapped on the first, membrane-distal domain of CD16. We demonstrate that mAbs 3G8, B88-9, CLB-Gran1, MEM- 154, and LNK16 almost completely block the receptor's interaction with IgG. Using chimeric Fc gamma RIIIB/Fc epsilon RI receptors and molecular modeling, we localized the epitopes of 3G8 and B88-9 on the putative FG loop of the membrane-proximal Ig-like domain, which we have previously identified as the major binding site for IgG. The epitopes of CLB-Gran1 and MEM-154 are shown to reside in proximity to the FG loop (probably BC or C'E loop). The blocking mAb LNK16 was detected to be directed against the putative C' beta-sheet of the membrane-proximal domain, suggesting that additional residues may be involved in IgG binding of Fc gamma RIII.


This article has been cited by other articles:


Home page
Cancer Res.Home page
N. Congy-Jolivet, A. Bolzec, D. Ternant, M. Ohresser, H. Watier, and G. Thibault
Fc{gamma}RIIIa Expression Is Not Increased on Natural Killer Cells Expressing the Fc{gamma}RIIIa-158V Allotype
Cancer Res., February 15, 2008; 68(4): 976 - 980.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Li, N. Jiang, S. Nagarajan, R. Wohlhueter, P. Selvaraj, and C. Zhu
Affinity and Kinetic Analysis of Fc{gamma} Receptor IIIa (CD16a) Binding to IgG Ligands
J. Biol. Chem., March 2, 2007; 282(9): 6210 - 6221.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
Q. Wei, J. W. Stallworth, P. J. Vance, J. A. Hoxie, and P. N. Fultz
Simian Immunodeficiency Virus (SIV)/Immunoglobulin G Immune Complexes in SIV-Infected Macaques Block Detection of CD16 but Not Cytolytic Activity of Natural Killer Cells.
Clin. Vaccine Immunol., July 1, 2006; 13(7): 768 - 778.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
I. Mende, P. Hoffmann, A. Wolf, R. Lutterbuse, E. Kopp, P. A. Baeuerle, A. de Baey, and P. Kufer
Highly efficient antigen targeting to M-DC8+ dendritic cells via Fc{gamma}RIII/CD16-specific antibody conjugates
Int. Immunol., May 1, 2005; 17(5): 539 - 547.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Oshima, A. Fujimura, G. Cartron, L. Dacheux, G. Salles, P. Solal-Celigny, P. Bardos, P. Colombat, and H. Watier
Implication for how the single nucleotide polymorphism (SNP) of Fc receptor, Fcgamma RIIIa alters the interaction with anti-CD20 monoclonal antibody
Blood, May 29, 2002; 99(12): 4649 - 4650.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. Chesla, P. Li, S. Nagarajan, P. Selvaraj, and C. Zhu
The Membrane Anchor Influences Ligand Binding Two-dimensional Kinetic Rates and Three-dimensional Affinity of Fcgamma RIII (CD16)
J. Biol. Chem., March 31, 2000; 275(14): 10235 - 10246.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. Craig Morton, G. van Zandbergen, C. van Kooten, C. J. Howard, J. G. J. van de Winkel, and P. Brandtzaeg
Immunoglobulin-binding Sites of Human Fcalpha RI (CD89) and Bovine Fcgamma 2R Are Located in their Membrane-distal Extracellular Domains
J. Exp. Med., June 7, 1999; 189(11): 1715 - 1722.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Zhu, K. J. Hamann, N. M. Munoz, N. Rubio, D. Mayer, A. Hernrreiter, and A. R. Leff
Intracellular Expression of Fc{gamma}RIII (CD16) and Its Mobilization by Chemoattractants in Human Eosinophils
J. Immunol., September 1, 1998; 161(5): 2574 - 2579.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. R. Koene, M. Kleijer, J. Algra, D. Roos, A. E.G.Kr. von dem Borne, and M. de Haas
Fcgamma RIIIa-158V/F Polymorphism Influences the Binding of IgG by Natural Killer Cell Fcgamma RIIIa, Independently of the Fcgamma RIIIa-48L/R/H Phenotype
Blood, August 1, 1997; 90(3): 1109 - 1114.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. E. Williams, S. Nagarajan, P. Selvaraj, and C. Zhu
Quantifying the Impact of Membrane Microtopology on Effective Two-dimensional Affinity
J. Biol. Chem., April 13, 2001; 276(16): 13283 - 13288.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. H. Vandorpe, S. Wilhelm, L. Jiang, O. Ibraghimov-Beskrovnaya, M. N. Chernova, A. K. Stuart-Tilley, and S. L. Alper
Cation channel regulation by COOH-terminal cytoplasmic tail of polycystin-1: mutational and functional analysis
Physiol Genomics, February 28, 2002; 8(2): 87 - 98.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.